Bonesupport Holding AB (BONEX.ST)

Executive Summary

Bonesupport Holding AB (BONEX.ST) is a Swedish biomedical company specializing in injectable synthetic bone graft substitutes based on its proprietary CERAMENT platform. The platform offers two key products: CERAMENT G (with gentamicin for infection) and CERAMENT V (antibiotic-free), indicated for trauma, revision arthroplasty, and chronic osteomyelitis. With commercial presence in Europe and the United States, the company has established a foothold in the orthopedic and infectious disease markets. Notably, CERAMENT G provides both mechanical support and localized antibiotic elution, addressing a critical unmet need in treating bone infections post-surgery. The company continues to expand its clinical evidence base, driving adoption among surgeons and supporting reimbursement in key regions.

Upcoming Catalysts (preview)

• Q4 2026FDA approval for expanded label of CERAMENT G in chronic osteomyelitis75% success
• Q1 2027Positive top-line results from Phase 3 trial of CERAMENT V in spinal fusion60% success
• Q3 2026Distribution partnership in Asia-Pacific region for CERAMENT products80% success